ConductScience.org, home

Paper6234037

Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions.

Kaplan J and 3 others. Blood, 1984. Cited by 324 papers, by iCite.

Cite this record

ConductScience Library. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Papers, record 6234037. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6234037

Download JSON
Disease
Iron deficiency anemia54 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions.
PubMed
Journal
Blood
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
324
iCite
Relative citation ratio, by iCite
13.8
iCite
Revised in PubMed
2022-03-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaplan JJ
2Sarnaik SS
3Gitlin JJ
4Lusher JJ

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Killer Cells, NaturalMajor topic
T-Lymphocytes, Helper-InducerMajor topic
T-Lymphocytes, RegulatoryMajor topic
Transfusion ReactionMajor topic
Adolescent
Adult
Anemia, Sickle Cell
Child
Child, Preschool
Fluorescent Antibody Technique
Hemophilia A
Humans
Middle Aged
Time Factors

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
HL 16008NHLBI NIH HHSUnited StatesP18HL016008PubMed and NIHNIH RePORTER
P60HL016008NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02628860Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating PancreatoduodenectomyResults

Source ClinicalTrials.gov

Download CSV of trials

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 324 citations.

PMIDTitleJournalYearIn PapersSource
38780623[Influence of anesthesia on surgical site infections].Anaesthesiologie2024https://conductscience.org/library/papers/38780623PubMed
37564949Efficacy of ferric carboxymaltose in iron deficiency anemia patients scheduled for pancreaticoduodenectomy.Ann Surg Treat Res2023https://conductscience.org/library/papers/37564949PubMed
36387093
Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection: A multicentre propensity score matching study.
Front Oncol2022https://conductscience.org/library/papers/36387093PubMed
35431506Assessment of pathogens and risk factors associated with bloodstream infection in the year after pediatric liver transplantation.World J Gastroenterol2022https://conductscience.org/library/papers/35431506PubMed
34405567Impact of portal hypertension on short- and long-term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis.Cancer Med2021https://conductscience.org/library/papers/34405567PubMed
33763245Prognostic impact of perioperative blood transfusions on oncological outcomes of patients with bladder cancer undergoing radical cystectomy: A systematic review.Arab J Urol2020https://conductscience.org/library/papers/33763245PubMed
33218187Is Laparoscopic Pancreaticoduodenectomy Feasible for Pancreatic Ductal Adenocarcinoma?Cancers (Basel)2020https://conductscience.org/library/papers/33218187PubMed
32411797Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis.J Immunol Res2020https://conductscience.org/library/papers/32411797PubMed
32382026Red blood cells exposed to cancer cells in culture have altered cytokine profiles and immune function.Sci Rep2020https://conductscience.org/library/papers/32382026PubMed
31861030Restrictive allogeneic blood transfusion strategy in patients with extremity bone sarcomas.Medicine (Baltimore)2019https://conductscience.org/library/papers/31861030PubMed
29416321Perioperative outcome of elderly versus younger patients undergoing major hepatic or pancreatic surgery.Clin Interv Aging2018https://conductscience.org/library/papers/29416321PubMed
29184878Prognostic factors after curative resection hepatocellular carcinoma and the surgeon's role.Ann Surg Treat Res2017https://conductscience.org/library/papers/29184878PubMed
28653142Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.World J Surg2017https://conductscience.org/library/papers/28653142PubMed
28488961Effect of storage period of red blood cell suspensions on helper T-cell subpopulations.Blood Transfus2018https://conductscience.org/library/papers/28488961PubMed
27237467Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.Am J Hematol2016https://conductscience.org/library/papers/27237467PubMed
27006592Impact of Transfusion on Cancer Growth and Outcome.Cancer Growth Metastasis2016https://conductscience.org/library/papers/27006592PubMed
26973413Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.World J Gastroenterol2016https://conductscience.org/library/papers/26973413PubMed
26926289The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review protocol.Syst Rev2016https://conductscience.org/library/papers/26926289PubMed
26676931Impact of Transfusion Threshold on Infectious Complications After Ileal Pouch-Anal Anastomosis.J Gastrointest Surg2016https://conductscience.org/library/papers/26676931PubMed
26121201Risk Factors for Bloodstream Infection After Living-donor Liver Transplantation in Children.Pediatr Infect Dis J2015https://conductscience.org/library/papers/26121201PubMed

See all 68 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
FERRIC CARBOXYMALTOSECHEMBL2108597Results1https://conductscience.org/library/drugs/CHEMBL2108597

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6234037

GET https://conductscience.org/api/papers/v1/6234037/cited_by?page=2